| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
ACER2
|
alkaline ceramidase 2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
ARL8B
|
ADP-ribosylation factor-like 8B
|
|
AS3MT
|
arsenite methyltransferase
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C9
|
complement component 9
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CANX
|
calnexin
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCND1
|
cyclin D1
|
|
CD19
|
CD19 molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD33
|
CD33 molecule
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD69
|
CD69 molecule
|
|
CD86
|
CD86 molecule
|
|
CD96
|
CD96 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CLDN14
|
claudin 14
|
|
CLDN4
|
claudin 4
|
|
CLDN8
|
claudin 8
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTAM
|
cytotoxic and regulatory T cell molecule
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSE
|
cathepsin E
|
|
CTSW
|
cathepsin W
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DBF4
|
DBF4 zinc finger
|
|
DCK
|
deoxycytidine kinase
|
|
DCPS
|
decapping enzyme, scavenger
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB103B
|
defensin, beta 103B
|
|
DGUOK
|
deoxyguanosine kinase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNM2
|
dynamin 2
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DRD1
|
dopamine receptor D1
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ENDOG
|
endonuclease G
|
|
ENO1
|
enolase 1, (alpha)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
EXO1
|
exonuclease 1
|
|
EXOSC5
|
exosome component 5
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FERMT3
|
fermitin family member 3
|
|
FOXM1
|
forkhead box M1
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GTSE1
|
G-2 and S-phase expressed 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMBOX1
|
homeobox containing 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK2
|
Janus kinase 2
|
|
JAKMIP1
|
janus kinase and microtubule interacting protein 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF7
|
kinesin family member 7
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LYST
|
lysosomal trafficking regulator
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MIR21
|
microRNA 21
|
|
MIR27A
|
microRNA 27a
|
|
MIR449A
|
microRNA 449a
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MT2A
|
metallothionein 2A
|
|
MT3
|
metallothionein 3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NT5C1A
|
5'-nucleotidase, cytosolic IA
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PHB
|
prohibitin
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PNLIPRP2
|
pancreatic lipase-related protein 2
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PSEN1
|
presenilin 1
|
|
PSMA1
|
proteasome (prosome, macropain) subunit, alpha type, 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTMA
|
prothymosin, alpha
|
|
PTOV1
|
prostate tumor overexpressed 1
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAET1E
|
retinoic acid early transcript 1E
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REPS1
|
RALBP1 associated Eps domain containing 1
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RHOG
|
ras homolog family member G
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
RND3
|
Rho family GTPase 3
|
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
|
RPSA
|
ribosomal protein SA
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFTPC
|
surfactant protein C
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH2D1B
|
SH2 domain containing 1B
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9
|
|
SIRT1
|
sirtuin 1
|
|
SIRT4
|
sirtuin 4
|
|
SLAMF6
|
SLAM family member 6
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC28A2
|
solute carrier family 28 (concentrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMAD3
|
SMAD family member 3
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STK4
|
serine/threonine kinase 4
|
|
STX11
|
syntaxin 11
|
|
STXBP2
|
syntaxin binding protein 2
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TALDO1
|
transaldolase 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBX21
|
T-box 21
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFR2
|
transferrin receptor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TMSB4Y
|
thymosin beta 4, Y-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TOLLIP
|
toll interacting protein
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TP53
|
tumor protein p53
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TTR
|
transthyretin
|
|
TXN
|
thioredoxin
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UBE2M
|
ubiquitin-conjugating enzyme E2M
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP3
|
UL16 binding protein 3
|
|
UPP1
|
uridine phosphorylase 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VSNL1
|
visinin-like 1
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZNF521
|
zinc finger protein 521
|
|
ZYX
|
zyxin
|
